MYRIAD GENETICS INC - MYGN

Sector: Healthcare · Industry: In Vitro & In Vivo Diagnostic Substances

Website: No information yet · Social: No information yet

Company profile

Latest / Compare

Q2 2026 · Q1 2026

Value (USD)

Total reported value ($000)

$602.5M

QoQ value delta ($000)

+$83.14M (+16.01%)

Implied price effect (QoQ)

+177.31%

Total shares

89,147,658

QoQ shares delta

-123,956,365 (-58.17%)

Total shares held by funds (by quarter)

Interactive chart by TradingView.

Top 25 only Full list

Partial Q2 2026 data: 197 holders have filed so far. Prior holders are carried forward until their next 13F confirms a change.

Manager	Value ($000)	Shares	% of 13F
PharVision Advisers, LLC	93,924	16,449	1.77%
BlackRock, Inc.	62,184	10,890,440	0.0%
MILLENNIUM MANAGEMENT LLC	37,802	6,620,372	0.01%
Vestal Point Capital, LP	32,746	5,735,000	0.77%
STATE STREET CORP	28,464	4,985,060	0.0%
D. E. Shaw & Co., Inc.	26,163	4,582,083	0.01%
VANGUARD CAPITAL MANAGEMENT LLC	23,304	4,081,376	0.0%
ACADIAN ASSET MANAGEMENT LLC	17,840	3,126,973	0.02%
VANGUARD PORTFOLIO MANAGEMENT LLC	17,584	3,079,670	0.0%
AQR CAPITAL MANAGEMENT LLC	15,797	2,766,689	0.01%
MORGAN STANLEY	14,167	2,481,104	0.0%
GEODE CAPITAL MANAGEMENT, LLC	13,800	2,416,197	0.0%
GOLDMAN SACHS GROUP INC	11,744	2,056,843	0.0%
JACOBS LEVY EQUITY MANAGEMENT, INC	10,800	1,891,527	0.04%
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	9,939	1,740,794	0.0%
Qube Research & Technologies Ltd	9,511	1,665,835	0.01%
CITADEL ADVISORS LLC	9,055	1,585,984	0.0%
FEDERATED HERMES, INC.	8,966	1,570,314	0.01%
TWO SIGMA INVESTMENTS, LP	8,894	1,557,727	0.01%
Nuveen, LLC	8,825	1,545,549	0.0%
MACKENZIE FINANCIAL CORP	8,768	1,535,702	0.01%
Connor, Clark & Lunn Investment Management Ltd.	8,038	1,407,860	0.02%
Aberdeen Group plc	7,474	1,308,933	0.01%
MARSHALL WACE, LLP	6,982	1,222,804	0.01%
DIMENSIONAL FUND ADVISORS LP	6,008	1,051,996	0.0%